|
Mitochondrial Dysfunction
|
0.00296
|
BCL2, NDUFA6, UQCRQ
|
|
Glycerol-3-phosphate shuttle
|
0.00672
|
GPD1
|
|
Glycerol degradation I
|
0.0101
|
GPD1
|
|
Death receptor signaling
|
0.0107
|
ACTC1, BCL2
|
|
VEGF signaling
|
0.013
|
ACTC1, BCL2
|
|
Oxidative phosphorylation
|
0.0145
|
NDUFA6, UQCRQ
|
|
Phosphatidylethanolamine biosynthesis II
|
0.0151
|
ETNK2
|
|
Pancreatic adenocarcinoma signaling
|
0.0169
|
BCL2, RALGDS
|
|
Gai signaling
|
0.0174
|
NPR3, RALGDS
|
|
nNOS signaling in skeletal muscle cells
|
0.025
|
SNTA1
|
|
Glutathione redox reactions I
|
0.0397
|
MGST3
|
|
NRF2-mediated oxidative stress response
|
0.0418
|
ACTC1, MGST3
|
|
ILK signaling
|
0.043
|
ACTC1, LIMS2
|
